These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36995078)

  • 1. Elucidating molecular and cellular targets and the antiprostate cancer potentials of promising phytochemicals: a review.
    Khan H; Rais J; Afzal M; Arshad M
    Anticancer Drugs; 2023 Sep; 34(8):910-915. PubMed ID: 36995078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure Based docking studies towards exploring potential anti-androgen activity of selected phytochemicals against Prostate Cancer.
    Singh AN; Baruah MM; Sharma N
    Sci Rep; 2017 May; 7(1):1955. PubMed ID: 28512306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer.
    Denmeade SR; Sena LA; Wang H; Antonarakis ES; Markowski MC
    Oncologist; 2023 Jun; 28(6):465-473. PubMed ID: 37027449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance.
    Lim SC; Jansson PJ; Assinder SJ; Maleki S; Richardson DR; Kovacevic Z
    FASEB J; 2020 Sep; 34(9):11511-11528. PubMed ID: 32713076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osajin displays potential antiprostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression.
    Huang SY; Huang GJ; Hsieh PF; Wu HC; Huang WC
    Prostate; 2019 Sep; 79(13):1543-1552. PubMed ID: 31299104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen action in the prostate gland.
    Yadav N; Heemers HV
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL; Lin JK
    Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.
    Yuan X; Li T; Wang H; Zhang T; Barua M; Borgesi RA; Bubley GJ; Lu ML; Balk SP
    Am J Pathol; 2006 Aug; 169(2):682-96. PubMed ID: 16877366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer.
    Kim Y; Kim J; Jang SW; Ko J
    Oncogene; 2015 Jan; 34(2):226-36. PubMed ID: 24441043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole induces AR degradation via endoplasmic reticulum stress pathway in androgen-dependent and castration-resistant prostate cancer cells.
    Wadosky KM; Shourideh M; Goodrich DW; Koochekpour S
    Prostate; 2019 Feb; 79(2):140-150. PubMed ID: 30280407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation.
    Naito M; Ikeda K; Aoyama S; Kanamoto M; Akasaka Y; Kido Y; Nakanishi M; Kanna M; Yamamotoya T; Matsubara A; Hinata N; Asano T; Nakatsu Y
    Cancer Med; 2023 Apr; 12(7):8464-8475. PubMed ID: 36583514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Receptor Dependence.
    Chaturvedi AP; Dehm SM
    Adv Exp Med Biol; 2019; 1210():333-350. PubMed ID: 31900916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
    Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
    J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
    Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities.
    Mia MAR; Dey D; Sakib MR; Biswas MY; Prottay AAS; Paul N; Rimti FH; Abdullah Y; Biswas P; Iftehimul M; Paul P; Sarkar C; El-Nashar HAS; El-Shazly M; Islam MT
    Phytother Res; 2023 Dec; 37(12):5724-5754. PubMed ID: 37786304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of androgens and the androgen receptor in prostate cancer.
    Debes JD; Tindall DJ
    Cancer Lett; 2002 Dec; 187(1-2):1-7. PubMed ID: 12359344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.